Bloated reserves undermine growth potential

Pharmaceutical companies are piling up internal reserves instead of investing for the future, undermining their growth potential. Companies opted to hold back their capital spending due to the uncertain business outlook and what they call inconsistent government policies.

The cash reserve ratio of the 55 listed firms reached 525 percent in their 2012 business plan, according to Yakup.com, a ...